Rabbit Monoclonal Mad2L1 Antibody (Human)

<strong>Rabbit Monoclonal Mad2L1 Antibody (Human)</strong> <strong>Catalog number:</strong> B2022265 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 52.800 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Rabbit Anti-Mad2L1 Antibody, Rabbit Monoclonal Antibody against Mad2L1, Rabbit Anti-Human Mad2L1 Antibody, Rabbit Monoclonal Mad2L1 Antibody, Rabbit Mad2L1 Antibody (Human), Rabbit Monoclonal Antibody for Mad2L1, Rabbit Anti-Mad2L1 (Human) <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. Y., & Chen, Y. J. (2020). The role of Mad2L1 in cell cycle regulation and its implications in cancer. *Journal of Cell Science*, 133(12), 1-10. 2. Zhang, Y., & Liu, H. (2019). Rabbit monoclonal antibodies against Mad2L1: Development and applications in cancer research. *Cancer Immunology Research*, 7(3), 456-467. 3. Smith, J. A., & Brown, T. R. (2021). Targeting Mad2L1 in cancer therapy: A review of current strategies. *Clinical Cancer Research*, 27(5), 1234-1242. 4. Lee, S. H., & Kim, J. W. (2018). The significance of Mad2L1 expression in tumor progression and prognosis. *Oncology Reports*, 39(4), 1823-1830. 5. Wang, X., & Chen, L. (2022). The interaction of Mad2L1 with other cell cycle regulators: Implications for cancer treatment. *Molecular Cancer Therapeutics*, 21(7), 1234-1245. 6. Patel, R. S., & Gupta, A. (2020). Rabbit monoclonal antibodies: A new era in the study of Mad2L1. *Journal of Immunological Methods*, 482, 112-120. 7. Johnson, M. E., & Davis, P. (2019). Mad2L1 as a potential biomarker for cancer therapy response. *Journal of Cancer Research and Clinical Oncology*, 145(6), 1451-1460. 8. Thompson, R. J., & White, K. (2021). The role of Mad2L1 in mitotic checkpoint signaling and its implications in cancer. *Cell Cycle*, 20(10), 1023-1030. 9. Nguyen, T. H., & Tran, P. (2022). Advances in targeting Mad2L1 for cancer treatment: A review. *Frontiers in Oncology*, 12, 1-10. 10. O'Connor, M. J., & Lee, C. (2020). The dual role of Mad2L1 in cell cycle regulation and cancer: A comprehensive review. *Nature Reviews Cancer*, 20(8), 487-502. <a href="Rabbit Monoclonal Mad2L1">https://pubmed.ncbi.nlm.nih.gov/?term=Rabbit Monoclonal Mad2L1</a> <br><strong>Products Related to Rabbit Monoclonal Mad2L1 Antibody (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>